Teva reports February 5

• Teva Pharmaceutical Industries (NYSE:TEVA +1.4%) will report Q4 and full-year results on February 5 before the open. The conference call will begin at 8:00 am ET.
• Consensus views for Q4 and 2014 are EPS of $1.31 and $5.07 on revenues of $5.2B and $20.3B, respectively.